Moors & Cabot’s Merck MRK Stock Holding History

Moors & Cabot’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-800	Closed	-$4K	–	882
2022 Q1	$4K	Buy	+800	New	+$63.1K	﹤0.01%	868
2021 Q4	–	Sell	-2,500	Closed	-$2K	–	946
2021 Q3	$2K	Buy	+2,500	New	+$190K	﹤0.01%	853
2020 Q4	–	Sell	-210	Closed	-$1K	–	762
2020 Q3	$1K	Buy	+210	New	+$16.4K	﹤0.01%	707
2019 Q4	–	Sell	-36,680	Closed	-$29K	–	673
2019 Q3	$29K	Buy	+36,680	New	+$2.94M	﹤0.01%	634
2015 Q2	–	Sell	-1,048	Closed	-$4K	–	538
2015 Q1	$4K	Buy	+1,048	New	+$59.3K	﹤0.01%	514

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Moors & Cabot's MRK Position: Q2 2026 in Review

Moors & Cabot reduced its Merck (MRK) stake by 1.5% in Q2 2026, selling an estimated $165K and leaving 94,665 shares worth $12.2M. The position accounts for 0.47% of the portfolio, ranked #46.

Moors & Cabot first reported a position in MRK in Q1 2014 and has held it in 50 quarters since. The position peaked at $19M in Q1 2024. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Moors & Cabot held 94,665 shares of Merck worth $12.2M as of Q2 2026.
Moors & Cabot sold 1,413 Merck shares in Q2 2026, an estimated $165K.
Merck made up 0.47% of Moors & Cabot's portfolio in Q2 2026, its #46 holding.
Moors & Cabot first reported a position in Merck in Q1 2014 and has held it in 50 quarters since.
Moors & Cabot's Merck position peaked at $19M in Q1 2024.
3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.